Quality indicators for systemic lupus erythematosus based on the 2019 EULAR recommendations: development and initial validation in a cohort of 220 patients
Katerina Chavatza, Myrto Kostopoulou, Dionysis Nikolopoulos, Ourania Gioti, K. Togia, Laura Andréoli, Martin Aringer, John Boletis, Andrea Doria, Frédéric Houssiau, David Jayne, Marta Mosca, Elisabet Svenungsson, Anǵela Tincani, George Βertsias, Antonis Fanouriakis, Dimitrios T. Boumpas
Topics & Concepts
MedicineHydroxychloroquineCohortInternal medicineRheumatismRheumatoid arthritisAdverse effectPrednisoneDiseaseInfectious disease (medical specialty)Coronavirus disease 2019 (COVID-19)Systemic Lupus Erythematosus ResearchRheumatoid Arthritis Research and TherapiesSpondyloarthritis Studies and Treatments